EPQ LLC CTYM PS 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 5:28 pm Sale | 2022-12-31 | 13G | Quince Therapeutics, Inc. QNCX | EPQ LLC CTYM PS | 1,576,720 4.400% | -1,286,376 (-44.93%) | Filing |
| 2021-02-01 4:25 pm Purchase | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | EPQ LLC CTYM PS | 2,863,096 9.710% | 36,300 (+1.28%) | Filing |